Cardiology Practice Guidelines

Recommendations for AF management highlight pharmacological and nonpharmacological approaches, as well as antithrombotic strategies.
SOURCE: ACC/AHA Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences, 2001

Designed to assess physicians' education, training, experience, and cognitive and technical skills necessary for the competent performance of invasive cardiac EPSs, catheter ablation, and cardioversion.
SOURCE: ACC/AHA/American College of Physicians-American Society of Internal Medicine Task Force on Clinical Competence, 2000

The purpose of this advisory is to summarize the currently available data concerning potential cardiovascular disease (CVD) benefits and risks associated with ERT/HRT and to provide updated clinical recommendations regarding its use in the secondary and primary prevention of CVD.
SOURCE: AHA Scientific Statement, 2001

Statement highlights risk factor management strategies that are appropriate for women with a broad range of cardiovascular disease risk.
SOURCE: AHA/ACC Scientific Statement: Consensus Panel Statement, 1999

An update to the existing set of practice guidelines from 1999.
SOURCE: ACC/AHA Task Force on Practice Guidelines (Committee to update (Committee to Update the 1999 Guidelines for the Management of Patients with Chronic Stable Angina). 2002

Statement stresses that aggressive risk factor management clearly improves patient survival, reduces recurrent events and the need for interventional procedures, and improves the quality of life for patients with atherosclerotic cardiovascular disease.
SOURCE: AHA/ACC Scientific Statement, 2001

Updated from 1993, guidelines account for the advent of new percutaneous coronary techniques and adjunctive medical therapies for the treatment of vascular narrowing. Guidelines provide information and make recommendations about appropriate use of technology for the diagnosis and treatment of patients with cardiovascular disease.
SOURCE: American College of Cardiology/American Heart Association (ACC/AHA) Task Force on Practice Guidelines, 2001

Advances in cardiac catheterizations have declined so markedly that older restrictions regarding the study of even higher-risk patients deserve reassessment.
SOURCE: American College of Cardiology Task Force on Clinical Expert Consensus Documents, 2001

Examines the scientific and societal implications of a new definition for MI and takes into account the fact that such changes in definition might have a profound effect on the traditional monitoring of disease rates and outcomes.
SOURCE: American College of Cardiology, 2000

These guidelines identify and recognize the importance of and rapid advances in the management of unstable angina and non-ST-segment elevation myocardial infarction.
SOURCE: ACC/AHA Task Force on Practice Guidelines, 2002

Discusses relationship between hypertension and dietary patterns associated with intake levels of sodium chloride, potassium, calcium, and other agents.
SOURCE: American Heart Association Nutrition Committee, 1998

Addressing primary care physicians, these revised guidelines provide recommendations for the contemporary approach to hypertension prevention and control.
SOURCE: National Heart, Lung, and Blood Institute, 1997

This document presents recommendations for reducing the risk of cardiovascular disease by dietary and other lifestyle practices by placing an increased emphasis on foods and an overall eating pattern and the need for all individuals to achieve and maintain a healthy body weight.
SOURCE: AHA Scientific Statement, 2000

Statement provides a clear and concise overview of the evidence regarding the importance of prevention by identifying various established and potential stroke risk factors.
SOURCE: AHA Scientific Statement, Stroke Council of the American Heart Association, 2001

The purpose of this statement is to present specific information regarding evaluation, intervention, and expected outcomes in specific core components of cardiac rehabilitation/secondary prevention programs.
SOURCE: AHA/AACVPR Scientific Statement, 2000